A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months

MRNA-1345OngoingActive not recruitingPhase 1Open NCT05743881 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…

NCT05743881 · Trial Tracker · ComplyRx